CNS Pharmaceuticals, Inc. Gains 48.02%

CNS Pharmaceuticals, Inc. (CNSP:NASDAQ) soared at $2.62, a gain of 48%. On Thu, Apr 20, 2023, CNSP:NASDAQ hit a New 2-Week Intraday High of $3.35. The stock appeared on our News Catalysts scanner on Mon, Apr 10, 2023 at 09:16 AM in the 'BIOTECH' category. From Thu, Apr 06, 2023, the stock recorded 33.33% Up Days and 40.00% Green Days

The stock spiked on Mon, Apr 17, 2023 at $4.4 with a volume of 41M+.

About CNS Pharmaceuticals, Inc. (CNSP:NASDAQ)

CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.